Structural optimization and structure-activity relationship studies of N-phenyl-7,8-dihydro-6H-pyrimido[5,4-b][1,4]oxazin-4-amine derivatives as a new class of inhibitors of RET and its drug resistance mutants-Reference-Cited by-同舟云学术

Structural optimization and structure-activity relationship studies of N-phenyl-7,8-dihydro-6H-pyrimido[5,4-b][1,4]oxazin-4-amine derivatives as a new class of inhibitors of RET and its drug resistance mutants

Published:2018-01 Issue: Volume:143 Page:1148-1164
ISSN:0223-5234
Container-title:European Journal of Medicinal Chemistry
language:en
Short-container-title:European Journal of Medicinal Chemistry

Author:

Yang Jiao,Chen Kai^ORCID,Zhang Guo,Yang Qiu-Yuan,Li Yue-Shan,Huang Shen-Zhen,Wang Yan-Lin,Yang Wei,Jiang Xiao-Juan,Yan Heng-Xiu,Zhu Jing-Qiang,Xiang Rong,Luo You-Fu,Li Wei-Min,Wei Yu-Quan,Li Lin-Li,Yang Sheng-Yong^ORCID

Funder

National Natural Science Foundation of China

Publisher

Elsevier BV

Subject

Organic Chemistry,Drug Discovery,Pharmacology,General Medicine

Reference39 articles.

1. A comprehensive overview of the role of the RET proto-oncogene in thyroid carcinoma;Romei;Nat. Rev. Endocrinol.,2016

2. Targeting the RET pathway in thyroid cancer;Wells;Clin. Cancer Res.,2009

3. CEP-701 and CEP-751 inhibit constitutively activated RET tyrosine kinase activity and block medullary thyroid carcinoma cell growth;Strock;Cancer Res.,2003

4. Medullary thyroid cancer in the past, present and future: from bench to bedside;Deshpande;Expert Rev. Endocrinol. Metab.,2014

5. RET proto-oncogene: a review and update of genotype-phenotype correlations in hereditary medullary thyroid cancer and associated endocrine tumors;Kouvaraki;Thyroid,2005

Cited by 15 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Recent progress of small-molecule of RET inhibitors against Non-small cell lung cancer;AAPS Open;2024-06-17

2. Unraveling the Promise of RET Inhibitors in Precision Cancer Therapy by Targeting RET Mutations;Journal of Medicinal Chemistry;2024-03-14

3. Repurposing Study of 4-Acyl-1-phenylaminocarbonyl-2-substituted-piperazine Derivatives as Potential Anticancer Agents—In Vitro Evaluation against Breast Cancer Cells;International Journal of Molecular Sciences;2023-12-01

4. Recent Advances in the Development of RET Inhibitors;Letters in Drug Design & Discovery;2023-03-06

5. 1-Methyl-3-((4-(quinolin-4-yloxy)phenyl)amino)-1H-pyrazole-4-carboxamide derivatives as new rearranged during Transfection (RET) kinase inhibitors capable of suppressing resistant mutants in solvent-front regions;European Journal of Medicinal Chemistry;2022-12